On 2025-04-29, BridgeBio Pharma, Inc. (BBIO) announced earnings per share of $-0.88 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-1.00.
The next expected annoucement date for quarterly earnings is 2025-08-07, with an average estimated earnings per share of $-0.74 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-04-29 | 2025-03-31 | $-1.00 | $-0.88 |
| 2025-02-20 | 2024-12-31 | $-1.09 | $-1.31 |
| 2024-11-12 | 2024-09-30 | $-1.03 | $-0.86 |
| 2024-08-01 | 2024-06-30 | $-1.09 | $-1.02 |
| 2024-05-02 | 2024-03-31 | $-0.40 | $-0.05 |
| 2024-02-22 | 2023-12-31 | $-0.95 | $-0.96 |
| 2023-11-02 | 2023-09-30 | $-0.86 | $-1.08 |
| 2023-08-03 | 2023-06-30 | $-0.86 | $-0.98 |
| 2023-05-04 | 2023-03-31 | $-0.84 | $-0.92 |
| 2023-02-23 | 2022-12-31 | $-0.86 | $-0.87 |
| 2022-11-03 | 2022-09-30 | $-1.02 | $-0.93 |
| 2022-08-04 | 2022-06-30 | $-0.92 | $-0.81 |
| 2022-05-05 | 2022-03-31 | $-1.13 | $-1.19 |
| 2022-02-24 | 2021-12-31 | $-0.83 | $-1.01 |
| 2021-11-04 | 2021-09-30 | $-0.91 | $-1.06 |
| 2021-08-05 | 2021-06-30 | $-0.93 | $-0.66 |
| 2021-05-06 | 2021-03-31 | $-0.87 | $-1.18 |
| 2021-02-25 | 2020-12-31 | $-0.86 | $-1.01 |
| 2020-11-05 | 2020-09-30 | $-0.97 | $-0.98 |
| 2020-08-11 | 2020-06-30 | $-0.79 | $-1.03 |
| 2020-05-13 | 2020-03-31 | $-0.69 | $-0.78 |
| 2020-03-02 | 2019-12-31 | $-0.70 | $-0.62 |
| 2019-11-07 | 2019-09-30 | $-0.55 | $-0.51 |